nz 107 has been researched along with amlexanox in 1 studies
| Studies (nz 107) | Trials (nz 107) | Recent Studies (post-2010) (nz 107) | Studies (amlexanox) | Trials (amlexanox) | Recent Studies (post-2010) (amlexanox) |
|---|---|---|---|---|---|
| 9 | 0 | 0 | 138 | 16 | 74 |
| Protein | Taxonomy | nz 107 (IC50) | amlexanox (IC50) |
|---|---|---|---|
| Multidrug resistance-associated protein 4 | Homo sapiens (human) | 2.2 | |
| Inhibitor of nuclear factor kappa-B kinase subunit epsilon | Homo sapiens (human) | 5.1143 | |
| Serine/threonine-protein kinase TBK1 | Homo sapiens (human) | 0.8506 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Daikoku, M; Iwama, T; Koda, A; Nagai, H; Suda, H; Yanagihara, Y | 1 |
1 other study(ies) available for nz 107 and amlexanox
| Article | Year |
|---|---|
Effect of NZ-107, a newly synthesized pyridazinone derivative, on antigen-induced contraction of human bronchial strips and histamine release from human lung fragments or leukocytes.
Topics: Aminopyridines; Asthma; Bronchi; Bronchoconstriction; Cromolyn Sodium; Histamine; Histamine Release; Humans; In Vitro Techniques; Interleukin-3; Lung; Pyridazines; SRS-A | 1992 |